skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 109  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Levosimendan in pulmonary hypertension and right heart failure
Material Type:
Article
Add to My Research

Levosimendan in pulmonary hypertension and right heart failure

Pulmonary Circulation, 2018-07, Vol.8 (3), p.1-7 [Peer Reviewed Journal]

The Author(s) 2018 ;The Author(s) ;The Author(s) 2018. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 2018 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/2045894018790905 ;PMID: 29979110

Full text available

2
MitraClip procedure as ‘bridge to list’, the ultimate therapeutic option for end-stage heart failure patients not eligible for heart transplantation due to severe pulmonary hypertension
Material Type:
Article
Add to My Research

MitraClip procedure as ‘bridge to list’, the ultimate therapeutic option for end-stage heart failure patients not eligible for heart transplantation due to severe pulmonary hypertension

Pulmonary circulation, 2018-10, Vol.8 (4), p.1-4 [Peer Reviewed Journal]

The Author(s) 2018 ;The Author(s) ;The Author(s) 2018. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 2018 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/2045894018791871 ;PMID: 30009662

Full text available

3
Elevated serum circ_0068481 levels as a potential diagnostic and prognostic indicator in idiopathic pulmonary arterial hypertension
Material Type:
Article
Add to My Research

Elevated serum circ_0068481 levels as a potential diagnostic and prognostic indicator in idiopathic pulmonary arterial hypertension

Pulmonary circulation, 2019-10, Vol.9 (4), p.1-9 [Peer Reviewed Journal]

The Author(s) 2019 ;The Author(s) ;The Author(s) 2019. ;The Author(s) 2019. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 2019 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/2045894019888416 ;PMID: 31827769

Full text available

4
Pulmonary hypertension in hereditary hemorrhagic telangiectasia: A clinical review
Material Type:
Article
Add to My Research

Pulmonary hypertension in hereditary hemorrhagic telangiectasia: A clinical review

Pulmonary circulation, 2023-10, Vol.13 (4), p.e12301-n/a [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute. ;2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1002/pul2.12301

Full text available

5
Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure
Material Type:
Article
Add to My Research

Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure

Pulmonary circulation, 2022-07, Vol.12 (3), p.e12096-n/a [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute. ;2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1002/pul2.12096 ;PMID: 35911182

Full text available

6
Iron deficiency in pulmonary arterial hypertension: perspectives
Material Type:
Article
Add to My Research

Iron deficiency in pulmonary arterial hypertension: perspectives

Pulmonary circulation, 2021-07, Vol.11 (3), p.1-4 [Peer Reviewed Journal]

The Author(s) 2021 ;The Author(s) ;The Author(s) 2021. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2021 2021 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/20458940211021301 ;PMID: 34178305

Full text available

7
Pulmonary arterial hypertension in pregnancy—a systematic review of outcomes in the modern era
Material Type:
Article
Add to My Research

Pulmonary arterial hypertension in pregnancy—a systematic review of outcomes in the modern era

Pulmonary Circulation, 2021-04, Vol.11 (2), p.1-9 [Peer Reviewed Journal]

The Author(s) 2021 ;The Author(s) ;The Author(s) 2021. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 2021 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/20458940211013671 ;PMID: 34104423

Full text available

8
Case series of 5 patients with end-stage renal disease with reversible dyspnea, heart failure, and pulmonary hypertension related to arteriovenous dialysis access
Material Type:
Article
Add to My Research

Case series of 5 patients with end-stage renal disease with reversible dyspnea, heart failure, and pulmonary hypertension related to arteriovenous dialysis access

Pulmonary circulation, 2015-06, Vol.5 (2), p.398-406 [Peer Reviewed Journal]

2015 by the Pulmonary Vascular Research Institute. All rights reserved. ;2015 Pulmonary Vascular Research Institute. All rights reserved. ;The Author(s) ;2015 Pulmonary Vascular Research Institute. All rights reserved.. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content ;2015 by the Pulmonary Vascular Research Institute. All rights reserved. 2015 Pulmonary Vascular Research Institute ;ISSN: 2045-8932 ;ISSN: 2045-8940 ;EISSN: 2045-8940 ;DOI: 10.1086/681266 ;PMID: 26064467

Full text available

9
The comparative effects of sacubitril/valsartan versus enalapril on pulmonary hypertension due to heart failure with a reduced ejection fraction
Material Type:
Article
Add to My Research

The comparative effects of sacubitril/valsartan versus enalapril on pulmonary hypertension due to heart failure with a reduced ejection fraction

Pulmonary circulation, 2022-07, Vol.12 (3), p.e12034-n/a [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute. ;2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1002/pul2.12034 ;PMID: 35874853

Full text available

10
A rare case of right heart failure with the necessity for veno-arterial extracorporeal membrane oxygenation following pulmonary vein stenosis after radiofrequency ablation for atrial fibrillation
Material Type:
Article
Add to My Research

A rare case of right heart failure with the necessity for veno-arterial extracorporeal membrane oxygenation following pulmonary vein stenosis after radiofrequency ablation for atrial fibrillation

Pulmonary circulation, 2023-01, Vol.13 (1), p.e12189-n/a [Peer Reviewed Journal]

2023 The Authors. Pulmonary Circulation published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute. ;2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 The Authors. published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute. ;ISSN: 2045-8932 ;ISSN: 2045-8940 ;EISSN: 2045-8940 ;DOI: 10.1002/pul2.12189 ;PMID: 36824692

Full text available

11
Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
Material Type:
Article
Add to My Research

Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension

Pulmonary circulation, 2019-10, Vol.9 (4), p.1-12 [Peer Reviewed Journal]

The Author(s) 2019 ;The Author(s) ;The Author(s) 2019. ;The Author(s) 2019. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/2045894019895452 ;PMID: 31903184

Full text available

12
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic
Material Type:
Article
Add to My Research

Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic

Pulmonary circulation, 2020-04, Vol.10 (2), p.1-7 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) ;The Author(s) 2020. ;The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 2020 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/2045894020920153 ;PMID: 32426111

Full text available

13
Diagnostic utility of sub-maximum cardiopulmonary exercise testing in the ambulatory setting for heart failure with preserved ejection fraction
Material Type:
Article
Add to My Research

Diagnostic utility of sub-maximum cardiopulmonary exercise testing in the ambulatory setting for heart failure with preserved ejection fraction

Pulmonary circulation, 2020-10, Vol.10 (4), p.1-10 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) ;The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 2020 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/2045894020972273 ;PMID: 33282205

Full text available

14
RNA-sequencing analysis of gene expression in a rat model of acute right heart failure
Material Type:
Article
Add to My Research

RNA-sequencing analysis of gene expression in a rat model of acute right heart failure

Pulmonary circulation, 2020-01, Vol.10 (1), p.1-13 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) ;The Author(s) 2020. ;The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 2020 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/2045894019879396 ;PMID: 32128157

Full text available

15
Growth differentiation factor-15 levels in the blood around the pulmonary artery is associated with hospitalization for heart failure in patients with pulmonary arterial hypertension
Material Type:
Article
Add to My Research

Growth differentiation factor-15 levels in the blood around the pulmonary artery is associated with hospitalization for heart failure in patients with pulmonary arterial hypertension

Pulmonary circulation, 2020-10, Vol.10 (4), p.1-6 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) ;The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 2020 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/2045894020962948 ;PMID: 33282189

Full text available

16
Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension
Material Type:
Article
Add to My Research

Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension

Pulmonary circulation, 2021-04, Vol.11 (2), p.1-10 [Peer Reviewed Journal]

The Author(s) 2021 ;The Author(s) ;The Author(s) 2021. ;The Author(s) 2021. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 2021 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/20458940211012366 ;PMID: 33996030

Full text available

17
Targeted therapy with phosphodiesterase 5 inhibitors in patients with pulmonary hypertension due to heart failure and elevated pulmonary vascular resistance: a systematic review
Material Type:
Article
Add to My Research

Targeted therapy with phosphodiesterase 5 inhibitors in patients with pulmonary hypertension due to heart failure and elevated pulmonary vascular resistance: a systematic review

Pulmonary circulation, 2020-07, Vol.10 (3), p.1-8 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) ;The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 2020 SAGE Publications Ltd, or Pulmonary Vascular Research Institute, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1177/2045894020948780 ;PMID: 33088478

Full text available

18
Right ventricular long noncoding RNA expression in human heart failure
Material Type:
Article
Add to My Research

Right ventricular long noncoding RNA expression in human heart failure

Pulmonary circulation, 2015-03, Vol.5 (1), p.135-161 [Peer Reviewed Journal]

2015 by the Pulmonary Vascular Research Institute. All rights reserved. ;2015 Pulmonary Vascular Research Institute. All rights reserved. ;The Author(s) ;2015 Pulmonary Vascular Research Institute. All rights reserved.. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content ;2015 by the Pulmonary Vascular Research Institute. All rights reserved. 2015 Pulmonary Vascular Research Institute ;ISSN: 2045-8932 ;ISSN: 2045-8940 ;EISSN: 2045-8940 ;DOI: 10.1086/679721 ;PMID: 25992278

Full text available

19
Emerging hemodynamic signatures of the right heart (Third International Right Heart Failure Summit, part 2)
Material Type:
Article
Add to My Research

Emerging hemodynamic signatures of the right heart (Third International Right Heart Failure Summit, part 2)

ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1086/678544

Full text available

20
Second International Pulmonary Hypertension/Heart Failure Symposium—Structural heart disease, right ventricular dysfunction, and stem cell therapy: The European Pediatric Pulmonary Vascular Disease Network
Material Type:
Article
Add to My Research

Second International Pulmonary Hypertension/Heart Failure Symposium—Structural heart disease, right ventricular dysfunction, and stem cell therapy: The European Pediatric Pulmonary Vascular Disease Network

Pulmonary circulation, 2023-01, Vol.13 (1), p.e12175-n/a [Peer Reviewed Journal]

2022 The Authors. published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute. ;2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-8940 ;ISSN: 2045-8932 ;EISSN: 2045-8940 ;DOI: 10.1002/pul2.12175 ;PMID: 36628260

Full text available

Results 1 - 20 of 109  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2011  (3)
  2. 2011 To 2013  (17)
  3. 2014 To 2016  (25)
  4. 2017 To 2020  (39)
  5. After 2020  (26)
  6. More options open sub menu

Searching Remote Databases, Please Wait